Alcon Inc. hisse başına yıllık % {var1} temettüye sahiptir ve % {var2} oranında bir getiri sunmaktadır. Temettü yıllık ödenmektedir ve son temettü hariç tarihi May 13, 2025 tarihindedir.
Dividend Yield
Yıllık Dividende
Özsermaye Tarihi
0.00%
$0.33
May 13, 2025
Ödeme Sıklığı
Ödeme Oranı
Yıllık
0.00%
Dividend History
Özsermaye Tarihi
Nakit Tutarı
Kayıt Tarihi
Ödeme Tarihi
May 13, 2025
$0.28
May 14, 2025
May 15, 2025
May 14, 2024
$0.24
May 15, 2024
May 16, 2024
May 10, 2024
$0.24
May 13, 2024
May 14, 2024
May 10, 2023
$0.21
May 11, 2023
May 12, 2023
May 3, 2022
$0.20
May 4, 2022
May 5, 2022
May 4, 2021
$0.10
May 5, 2021
May 6, 2021
Dividend Grafikleri
ALC Kâr Payları
ALC Dividend Growth (Yıllık Üstünlük)
Follow-Up Questions
Alcon Inc.'in şu anki temettü ödemesi ve yıllık temettüsü nedir?
Alcon Inc.'in temettü ödeme oranı nedir?
ALC'ün temettü dağıtım tarihi nedir?
Alcon Inc. ne sıklıkla temettü öder?
360Rapor
Önemli İstatistikler
Önceki Kapanış
$78.37
Açılış fiyatı
$77.44
Günün Aralığı
$77.44 - $78.88
52 haftalık aralık
$71.55 - $99.2
İşlem hacmi
1.9M
Ort.Hacim
1.6M
EPS (TTM)
2.10
Dividend yield
--
Piyasa Değeri
$38.7B
Alcon Inc. nedir?
Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. The company is headquartered in Fribourg, Fribourg and currently employs 25,599 full-time employees. The company went IPO on 2019-04-09. The firm research, develop, manufacture, distribute and sell a full suite of eye care products within two key businesses: Surgical and Vision Care. The Company’s Surgical business is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery. The surgical portfolio includes implantables, consumables and surgical equipment required for these procedures and supports the end-to-end needs of the ophthalmic surgeon. The Company’s Vision Care business comprises of daily disposable, reusable and color-enhancing contact lenses and a portfolio of ocular health products, including products for dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The firm operates in 60 countries and serves consumers and patients in over 140 countries.